FPT-SOFTWARE
Vietnam's leading IT services provider FPT Software, a member company of FPT Corporation, announced its new alliance with Julie Sandlau, one of the world's leading jewelry producers, supporting the company to build its first smart jewelry manufacturing factory in Vietnam. The partnership is expected to enhance FPT Software's presence in the Nordic region and incorporate digital technologies into Julie Sandlau's production line, revolutionizing it with Smart factories, Artificial Intelligence, Robotics, and so on.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221101005835/en/
FPT Software and Julie Sandlau signed the strategic partnership (Photo: Business Wire)
The signing ceremony took place on November 1st, in Hanoi, Vietnam, within the framework of Vietnam-Denmark Business Summit Forum 2022, organized by the Embassy of Denmark in Vietnam, Vietnamese Government Office and the Vietnamese Ministry of Foreign Affair in Denmark.
Through this alliance, FPT Software becomes Julie Sandlau’s strategic partner, provides the company with an exclusive roadmap to build their first Smart factory and transform the traditional jewelry manufacturing process with digital technologies like Robotic Process Automation, Artificial Intelligence, and more. The new manufacturing plant is set to be completed by the end of 2023 in Hoa Lac Hi-tech Park, Vietnam's first and largest hi-tech industrial zone.
The newly established partnership also transforms Julie Sandlau's operations and work processes, from human resources, operational management, to accounting and so on. FPT Software's automation and robotic processing solutions help ease the usual back-office procedures, reduce workload and workforce, thereby promoting and accompanying Julie Sandlau's towards sustainable development. The strategic step also allows Julie Sandlau's to expand its operations to a strategic market like Vietnam and target potential customers here.
FPT Corporation Chairman Dr Truong Gia Binh said. “In the past five decades, Vietnam and Denmark have established a strong relationship, with many deals among companies of both countries. With this partnership with Julie Sandlau, FPT believes that we can help reinforce the tight relationship between both nations.”
“As Vietnam’s leading IT solutions provider, FPT is confident to help Julie Sandlau with their digital transformation process and expansion goals in the Vietnamese and Southeast Asian markets”, Chairman Binh added.
“Vietnam always has a special place in our hearts since we started our business in 2006 here in Hanoi, so we are very excited to continue our Vietnam journey investing and developing further into digitalization, AI, blockchain technology and robotics.”, said Julie Sandlau’s CEO Soren Roed Pedersen.
“For years we have been first movers with our strong focus on ESG and we are now ready to start our digital transformation together with FPT and thus further proving the great collaboration between Vietnam and Denmark. We find the core values and vision of FPT and Julie Sandlau are a great match as we aim to transform a jewelry industry from traditional manufacturing methods to a modern digital hub. We have obviously great ambitions for our partnership with FPT as our long term strategy for Vietnam will develop into much more than just manufacturing.”, he further added.
"Julie Sandlau is our first-ever client in the jewelry manufacturing industry. This gives us more opportunities to explore and amplify FPT Software's technology potentials, especially in building a smart manufacturing factory for a client in a peculiar industry as such.”, FPT Software Europe CEO Hai Le said. "I believe this partnership will allow us to strengthen our workforce and experience, particularly in providing digital transformation solutions for future manufacturing clients.", he added.
On nurturing and developing human resources, FPT Software will transfer expertise and provide comprehensive training to Julie Sandlau's employees in Vietnam, with a deep dive into Artificial Intelligence applications. This practice will turn Julie Sandlau the world's first jewelry manufacturer to involve emerging technology in its production process, supporting its goal of becoming a digital transformation hero in premium accessories production by 2025.
The strategic partnership allows the two companies' employees to exchange knowledge and experiences, with Julie Sandlau offering fresh graduates from FPT University and FPT Corporation's staffs internship and employment opportunities. The program aims to improve educational quality and develop a guaranteed career path for future industrial engineers for FPT students and employees.
About FPT Software
FPT Software is a part of FPT Corporation, a globally leading technology and IT services & solutions provider headquartered in Vietnam with nearly US$1.6 billion in revenue and 41,000 employees in 27 countries. As a pioneer in digital transformation, it delivers world-class services in Smart factories, Digital platforms, RPA, AI, IoT, Enterprise Mobility, Digital Product Development, Cloud, AR/VR, Business Applications, Application Services, Managed Services, and so on. The company has served 1,000+ customers worldwide, nearly 100 of which are Fortune Global 500 companies in the industries of Aerospace & Aviation, Manufacturing & Automotive, Banking, Finance & Insurance, Logistics & Transportation, Healthcare & Life Sciences, Retail, Utilities & Energy, and more. For further information, please visit http://www.fpt-software.com.
About Julie Sandlau
Julie Sandlau Vietnam is the manufacturing arm of Danish luxury Jewelry brand Julie Sandlau and have since 2006 been producing high quality jewelry for some of the largest jewelry brands in the world with a strong focus on environment, sustainability and governance. The factory is committed to the United Nations Global Compact, The UN Women Empowerment Principles, The Science Based Target Initiative and is a certified member of the Responsible Jewellery Council, the highest international standard of responsible business practices in the jewelry business. With a workforce of nearly 400 people in which the goldsmiths are specialised and educated in Danish craftsmanship traditions and skills, Julie Sandlau Vietnam has been a first mover in CSR in Vietnam for years, winning multiple awards. All Julie Sandlau Vietnam's jewelry are made from recycled precious metals and sustainable certified gem stones giving their customers and stakeholders the ultimate trust and confidence in mutual business.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221101005835/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom